Pre-exposure Prophylaxis (PrEP) Adherence for Black MSM (NCT06661343)
A Multi-Level Integrated Strategy to Optimize PrEP Adherence for Black MSM and Accelerate Implementation at Scale
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to learn if two interventions-C4 and C4+3MV-can improve PrEP adherence (taking medication to prevent HIV) among Black men who have sex with men (MSM). The study will also explore the most effective ways to support participants in continuing their PrEP use over time. The main questions it aims to answer are: * Does the C4 program help participants take PrEP more regularly? * Does adding the 3MV intervention to C4 provide additional support for adherence? Researchers will compare two intervention strategies to see if they result in better PrEP adherence: * C4 Intervention: A program focused on individualized care coordination and addressing structural needs. * C4 + 3MV Intervention: A combination of care coordination with additional behavioral change sessions. Participants will: * Participate in PrEP education and counseling sessions. * Have their PrEP use monitored through dried blood spot (DBS) tests. * Complete questionnaires about their experiences and challenges with PrEP. Receive support sessions tailored to address individual barriers to PrEP adherence.
Who can join: Review the eligibility criteria below.
Location: Bronx Health Center — New York, New York
Age range: 18 Years
🧪 Interventions in This Study
- C4 Program (BEHAVIORAL)
- C4 + 3MV Program (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Bronx Health Center — New York, New York
- Abounding Prosperity, Inc. — Dallas, Texas
📞 Contact the Study Coordinator
Phone: (203) 737-2339
Email: ysn.c4_3mvstudy@yale.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in HIV Prevention
- PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study) — Galveston, Texas
- Integrated HIV Prevention and HCV Care for PWID — Miami, Florida
- Clinic-based HIV Identification and Prevention Project Using Electronic Resources — Baltimore, Maryland
- Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW — Los Angeles, California
- Examining Migration, Social Bonds, Transnationalism, and HIV Prevention Pathways Among African Immigrants. — Buffalo, New York
- PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men — Miami, Florida
Explore by condition: All HIV Prevention clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.